Alliance Pharmaceutical has completed a 1:5 reverse stock split, effective today. Shareholders of the San Diego-based firm approved the reverse stock split at Alliance's annual shareholder meeting on October 15.
By AuntMinnie.com staff writersOctober 18, 2001
Related Reading
Alliance to launch prostate imaging study, October 8, 2001
Alliance wins patent interference ruling against Nycomed, September 20, 2001
Alliance closes in on Imavist clearance, August 20, 2001
Nycomed Amersham expands ultrasound efforts as Mallinckrodt exits sector, August 6, 2001
Alliance completes purchase of MBI, January 3, 2001
Copyright © 2001 AuntMinnie.com
